Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
3(43%)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_3
3
43%
Ph phase_2
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

2 of 6 finished

Non-Completion Rate

66.7%

4 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(2)
Terminated(4)
Other(1)

Detailed Status

Terminated3
Completed2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
40.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 33 (50.0%)
N/A2 (33.3%)

Trials by Status

unknown114%
completed229%
withdrawn114%
terminated343%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix

NCT02518594
completed

Arabin Pessary in Singleton Pregnancy

NCT04638023
terminatedphase_3

Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies

NCT03052270
terminatednot_applicable

Cervical Pessary for Prevention of Spontaneous Preterm Birth in Singleton Pregnancies With Arrested Preterm Labor

NCT03543475
terminatednot_applicable

Cervical Pessary to Prevent Preterm Birth in Singleton Pregnancies With a Sonographically Measured Short Cervix

NCT02357394
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02518594Phase 3

A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix

Completed
NCT04638023

Arabin Pessary in Singleton Pregnancy

Completed
NCT03052270Phase 3

Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies

Terminated
NCT03543475Not Applicable

Cervical Pessary for Prevention of Spontaneous Preterm Birth in Singleton Pregnancies With Arrested Preterm Labor

Terminated
NCT02357394Not Applicable

Cervical Pessary to Prevent Preterm Birth in Singleton Pregnancies With a Sonographically Measured Short Cervix

Terminated
NCT02967445Phase 3

Physical Examination-Indicated Pessary

Withdrawn
NCT03058536Phase 2

Progesterone and Cervical Pessary in Twins

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
7